论文部分内容阅读
1989年Limas首次提出扩张型心肌病(DCM)患者的血清中有抗β1肾上腺素受体(antiβ1-AR)自身抗体存在[1]。研究表明β1-AR自身抗体在DCM的致病机制中发挥重要作用。本研究对于抗β1-AR自身抗体水平及左室舒张末期容积(LVEDV)的关系进行了分析。1对象和方法我院2006年1月～2007年7
1989 Limas first proposed in patients with dilated cardiomyopathy (DCM) serum anti-β1 adrenergic receptor (antiβ1-AR) autoantibodies exist [1]. Studies have shown that β1-AR autoantibodies play an important role in the pathogenesis of DCM. This study analyzed the relationship between anti-β1-AR autoantibodies and left ventricular end diastolic volume (LVEDV). 1 objects and methods in our hospital from January 2006 to 2007 7